AIM: To determine the effects of allopurinol, an inhibitor of xanthine oxidase, and apocynin, an inhibitor of NADPH oxidase, on oxidant stress and liver injury caused by hepatic ischemia/reperfusion (I/R) procedure in mice. METHODS: Mice were pretreated with a xanthine oxidase inhibitor, allopurinol, or NADPH oxidase (NOX) inhibitor, apocynin before the hepatic I/R procedure. Then treated or untreated mice underwent the hepatic I/R procedure. The effects on hepatic injury and superoxide anions were determined after starting reperfusion. RESULTS: A standard warm hepatic I/R procedure led to a marked increase in superoxide anion production as indicated by a superoxide anion tracer, MCLA. At the same time, the procedure caused profound acute liver injury, as indicated by elevated serum alanine aminotransferase and tumor necrosis factor-alpha levels, reduced liver glutathione levels and elevated malondialdehyde contents, as well as a high apoptotic cell count. All these changes were reversed by the use of apocynin or allopurinol prior to the hepatic I/R procedure. CONCLUSION: Allopurinol and apocynin exerted protective effects on hepatic ischemia/reperfusion injury. The protection is associated with blocking the generation of superoxide anions during the hepatic I/R procedure by inhibiting xanthine oxidase and NADPH oxidase activity.
AIM: To determine the effects of allopurinol, an inhibitor of xanthine oxidase, and apocynin, an inhibitor of NADPH oxidase, on oxidant stress and liver injury caused by hepatic ischemia/reperfusion (I/R) procedure in mice. METHODS:Mice were pretreated with a xanthine oxidase inhibitor, allopurinol, or NADPH oxidase (NOX) inhibitor, apocynin before the hepatic I/R procedure. Then treated or untreated mice underwent the hepatic I/R procedure. The effects on hepatic injury and superoxide anions were determined after starting reperfusion. RESULTS: A standard warm hepatic I/R procedure led to a marked increase in superoxide anion production as indicated by a superoxide anion tracer, MCLA. At the same time, the procedure caused profound acute liver injury, as indicated by elevated serum alanine aminotransferase and tumor necrosis factor-alpha levels, reduced liver glutathione levels and elevated malondialdehyde contents, as well as a high apoptotic cell count. All these changes were reversed by the use of apocynin or allopurinol prior to the hepatic I/R procedure. CONCLUSION:Allopurinol and apocynin exerted protective effects on hepatic ischemia/reperfusion injury. The protection is associated with blocking the generation of superoxide anions during the hepatic I/R procedure by inhibiting xanthine oxidase and NADPH oxidase activity.
Authors: M von Frankenberg; M Golling; A Mehrabi; H Nentwich; J Thies; F Schaeffer; C Jahnke; O Bud; M M Gebhard; G Otto; R G Thurman; C Herfarth; E Klar Journal: Transplant Proc Date: 1999-12 Impact factor: 1.066
Authors: Y Yabe; N Kobayashi; T Nishihashi; R Takahashi; M Nishikawa; Y Takakura; M Hashida Journal: J Pharmacol Exp Ther Date: 2001-09 Impact factor: 4.030
Authors: H Kono; I Rusyn; T Uesugi; S Yamashina; H D Connor; A Dikalova; R P Mason; R G Thurman Journal: Am J Physiol Gastrointest Liver Physiol Date: 2001-05 Impact factor: 4.052
Authors: Hirohisa Harada; Ian N Hines; Sonia Flores; Bifeng Gao; Joe McCord; Helen Scheerens; Matthew B Grisham Journal: Arch Biochem Biophys Date: 2004-03-01 Impact factor: 4.013
Authors: Ulvi Demirel; Mehmet Yalniz; Cem Aygün; Cemal Orhan; Mehmet Tuzcu; Kazim Sahin; Ibrahim Hanifi Ozercan; Ibrahim Halil Bahçecioğlu Journal: Inflammation Date: 2012-08 Impact factor: 4.092
Authors: Shruti Sharma; Sanjiv Kumar; Dean A Wiseman; Suphin Kallarackal; Sumant Ponnala; Manal Elgaish; Jing Tian; Jeffrey R Fineman; Stephen M Black Journal: Vascul Pharmacol Date: 2010-03-31 Impact factor: 5.773
Authors: Jonathan Jun; Vladimir Savransky; Ashika Nanayakkara; Shannon Bevans; Jianguo Li; Philip L Smith; Vsevolod Y Polotsky Journal: Am J Physiol Regul Integr Comp Physiol Date: 2008-08-13 Impact factor: 3.619